NO20050134L - Diphenyllazidide ions substituted with acid groups, process for their preparation, drugs containing these compounds and their use - Google Patents

Diphenyllazidide ions substituted with acid groups, process for their preparation, drugs containing these compounds and their use

Info

Publication number
NO20050134L
NO20050134L NO20050134A NO20050134A NO20050134L NO 20050134 L NO20050134 L NO 20050134L NO 20050134 A NO20050134 A NO 20050134A NO 20050134 A NO20050134 A NO 20050134A NO 20050134 L NO20050134 L NO 20050134L
Authority
NO
Norway
Prior art keywords
compounds
diphenyllazidide
preparation
acid groups
drugs containing
Prior art date
Application number
NO20050134A
Other languages
Norwegian (no)
Other versions
NO20050134D0 (en
Inventor
Heiner Glombik
Hubert Heuer
Werner Kramer
Wendelin Frick
Hans-Ludwig Schaefer
Andreas Lindenschmidt
Gerhard Jaehne
Stefanie Flohr
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NO20050134D0 publication Critical patent/NO20050134D0/en
Publication of NO20050134L publication Critical patent/NO20050134L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Oppfinnelsen vedrører forbindelser av formel (1), hvor R1- R6 har den angitte betydning, så vel som deres fysiologisk akseptable salter. Forbindelsene egner seg for eksempel som hyperlipidemiske midler.The invention relates to compounds of formula (1), wherein R 1 -R 6 have the indicated meaning, as well as their physiologically acceptable salts. The compounds are suitable, for example, as hyperlipidemic agents.

NO20050134A 2002-06-19 2005-01-11 Diphenyllazidide ions substituted with acid groups, process for their preparation, drugs containing these compounds and their use NO20050134L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10227508A DE10227508A1 (en) 2002-06-19 2002-06-19 Acid group-substituted diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use
PCT/EP2003/005816 WO2004000805A1 (en) 2002-06-19 2003-06-04 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof

Publications (2)

Publication Number Publication Date
NO20050134D0 NO20050134D0 (en) 2005-01-11
NO20050134L true NO20050134L (en) 2005-03-18

Family

ID=29719283

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050134A NO20050134L (en) 2002-06-19 2005-01-11 Diphenyllazidide ions substituted with acid groups, process for their preparation, drugs containing these compounds and their use

Country Status (28)

Country Link
EP (1) EP1517891B1 (en)
JP (1) JP2005533073A (en)
KR (1) KR20050008835A (en)
CN (1) CN100467448C (en)
AR (1) AR039690A1 (en)
AU (1) AU2003238210B2 (en)
BR (1) BR0311896A (en)
CA (1) CA2490112A1 (en)
DE (1) DE10227508A1 (en)
EC (1) ECSP045497A (en)
HN (1) HN2003000185A (en)
HR (1) HRPK20041201B3 (en)
IL (1) IL165789A0 (en)
MA (1) MA27206A1 (en)
MX (1) MXPA04012093A (en)
NO (1) NO20050134L (en)
OA (1) OA12869A (en)
PA (1) PA8576101A1 (en)
PE (1) PE20040564A1 (en)
PL (1) PL372700A1 (en)
RS (1) RS108404A (en)
RU (1) RU2287522C2 (en)
SV (1) SV2004001548A (en)
TN (1) TNSN04250A1 (en)
TW (1) TW200413311A (en)
UA (1) UA78577C2 (en)
UY (1) UY27853A1 (en)
WO (1) WO2004000805A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
CA2550215A1 (en) 2003-12-23 2005-07-07 Astrazeneca Ab Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
WO2006060461A1 (en) 2004-12-03 2006-06-08 Schering Corporation Substituted piperazines as cb1 antagonists
US8361999B2 (en) 2005-04-04 2013-01-29 Pontificia Universidad Catolica De Chile Methods of treating cholesterol gallstone disease with ezetimibe
JP2008546784A (en) 2005-06-20 2008-12-25 シェーリング コーポレイション Piperidine derivatives useful as histamine H3 antagonists
SA06270191B1 (en) 2005-06-22 2010-03-29 استرازينيكا ايه بي Novel 2-Azetidinone Derivatives as Cholesterol Absorption Inhibitors for the Treatment of Hyperlipidaemic Conditions
AR060623A1 (en) 2006-04-27 2008-07-02 Astrazeneca Ab COMPOUNDS DERIVED FROM 2-AZETIDINONE AND A PREPARATION METHOD
CA2655604C (en) * 2006-06-23 2016-08-09 Abbott Laboratories Cyclopropyl amine derivatives
BRPI0715160A2 (en) 2006-08-08 2013-06-11 Sanofi Aventis arylamimoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, drugs comprising these compounds, and their use
DE102007002260A1 (en) 2007-01-16 2008-07-31 Sanofi-Aventis Use of substituted pyranonic acid derivatives for the preparation of medicaments for the treatment of the metabolic syndrome
EP2025674A1 (en) 2007-08-15 2009-02-18 sanofi-aventis Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
CN101200443B (en) * 2007-10-17 2011-06-29 中国药科大学 Nitrogen heterocyclic methyl ethyl ketone derivatives, preparation method and medicine combination containing the same
DE102007054497B3 (en) 2007-11-13 2009-07-23 Sanofi-Aventis Deutschland Gmbh Novel crystalline diphenylazetidinone hydrates and process for their preparation
WO2010003624A2 (en) 2008-07-09 2010-01-14 Sanofi-Aventis Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
WO2010100255A1 (en) 2009-03-06 2010-09-10 Lipideon Biotechnology Ag Pharmaceutical hypocholesterolemic compositions
CN101993403B (en) 2009-08-11 2012-07-11 浙江海正药业股份有限公司 Azetidinone compound and medical applications thereof
DK2470552T3 (en) 2009-08-26 2014-02-17 Sanofi Sa NOVEL, CRYSTALLINE, heteroaromatic FLUORGLYCOSIDHYDRATER, MEDICINES COVERING THESE COMPOUNDS AND THEIR USE
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
WO2012120056A1 (en) 2011-03-08 2012-09-13 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
US8710050B2 (en) 2011-03-08 2014-04-29 Sanofi Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683704B1 (en) 2011-03-08 2014-12-17 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2766349B1 (en) 2011-03-08 2016-06-01 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
WO2012120054A1 (en) 2011-03-08 2012-09-13 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
AU2019318209B2 (en) 2018-08-10 2025-09-25 Diapin Therapeutics, Llc Tri-peptides and treatment of metabolic, cardiovascular and inflammatory disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3300B (en) * 1992-12-23 1995-06-26 Schering Corp Combination of a cholesterol biosynhtesis inhibitor and a beta- lactam cholesterol absorbtion inhibitor
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US5756470A (en) * 1996-10-29 1998-05-26 Schering Corporation Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
RU2181297C2 (en) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Method of treatment of pathological syndrome and medicinal agent
DE10042447A1 (en) * 2000-08-29 2002-03-28 Aventis Pharma Gmbh Vertebrate intestinal protein that absorbs cholesterol and use of this protein to identify inhibitors of intestinal cholesterol transport
IL156552A0 (en) * 2000-12-21 2004-01-04 Aventis Pharma Gmbh Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
HRP20030501A2 (en) * 2000-12-21 2005-04-30 Aventis Pharma Deutschland Gmbh Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
HUP0401081A3 (en) * 2000-12-21 2010-06-28 Sanofi Aventis Deutschland Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and their use

Also Published As

Publication number Publication date
BR0311896A (en) 2005-04-05
JP2005533073A (en) 2005-11-04
HRP20041201A2 (en) 2005-08-31
DE10227508A1 (en) 2004-01-08
AU2003238210B2 (en) 2008-10-23
KR20050008835A (en) 2005-01-21
MXPA04012093A (en) 2005-04-19
CA2490112A1 (en) 2003-12-31
HK1079511A1 (en) 2006-04-07
RS108404A (en) 2007-02-05
HN2003000185A (en) 2005-10-20
SV2004001548A (en) 2004-03-19
OA12869A (en) 2006-09-15
EP1517891B1 (en) 2013-04-03
NO20050134D0 (en) 2005-01-11
ECSP045497A (en) 2005-03-10
MA27206A1 (en) 2005-01-03
IL165789A0 (en) 2006-01-15
AU2003238210A1 (en) 2004-01-06
PL372700A1 (en) 2005-07-25
TNSN04250A1 (en) 2007-03-12
WO2004000805A1 (en) 2003-12-31
PA8576101A1 (en) 2004-02-07
TW200413311A (en) 2004-08-01
RU2005101093A (en) 2005-07-20
CN1662495A (en) 2005-08-31
PE20040564A1 (en) 2004-10-25
EP1517891A1 (en) 2005-03-30
RU2287522C2 (en) 2006-11-20
UY27853A1 (en) 2003-12-31
UA78577C2 (en) 2007-04-10
CN100467448C (en) 2009-03-11
HRPK20041201B3 (en) 2006-12-31
AR039690A1 (en) 2005-03-09

Similar Documents

Publication Publication Date Title
NO20012158L (en) Substituted 2-phenylbenzimidazoles, process for preparation and use thereof
NO20085068L (en) Phenylamino-benzoxazole-substituted carboxylic acids, process for their preparation and use thereof as medicaments
NO20052493L (en) Selected CGRP antagonists, processes for their preparation and their use as pharmaceutical compositions.
NO20055219L (en) New connections
TN2009000180A1 (en) NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF
TNSN04250A1 (en) Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof.
NO20055568L (en) Substituted 1,4-diazepines and uses thereof
NO20055688L (en) Organic compounds
YU65804A (en) Novel heterocyclic compounds which are active as inhibitors of beta-lactamases
NO20060195L (en) Quinolylamide derivatives as CCR-5 antagonists
MEP41408A (en) Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter
NO20060342L (en) 1-sulfonylindole derivatives, their preparation and their use as 5-HT6 ligands
NO20070089L (en) DPP-IV inhibitors
MA27232A1 (en) N-BENZOYLUREIDOCINNAMIC ACID DERIVATIVES, PREPARATION METHODS AND USES THEREOF
NO20082727L (en) Salts of 9-oxoacridine-10-acetic acid with 1-alkylamino-1-deoxy polyols
DE50113943D1 (en) 4-ALKOXY-CYCLOHEXAN-1-AMINO-CARBOXYLIC ACID ESTERS AND METHOD FOR THE PRODUCTION THEREOF
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
NO20044881L (en) Acyl-3-carboxyphenylurea derivatives, preparation method and use thereof
HRP20041208A2 (en) Pyrrolidine derivatives as oxytocin antagonists
NO20060383L (en) Substituted diketopiperazines and their use as oxytocin antagonists
NO20060155L (en) Indole-4-sulfonamide derivatives, their preparation and their use 5-HT-6 as modulators
NO20060718L (en) Substituted thiophones and their use
NO20062533L (en) 5-fluoro, 5-chloro and cyanopyridin-2-yl-tetrazoles as ligands for the metabotrophic glutamate receptor-5
NO20063859L (en) Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and use thereof as medicaments
NO330964B1 (en) Kolkisosidanaloger

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application